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Abstract : A clearer understanding of skeletal muscle mass (SMM) in middle-aged and elderly individuals is im-
portant for maintaining functionality. In the present study, age-related changes in SMM, the threshold of SMM 
with walking difficulty, intestinal nutrient absorption rate, and various serum factors were examined in Japa-
nese populations of different ages. We used 24-h creatinine excretion as a measure of total body SMM. Age-related 
decreases in SMM, intestinal nutrient absorption rates, and serum 25-hydroxyvitamin D [25(OH)D] concentra-
tions were significantly higher in women than in men. The cut-off values for SMM (kg), its percentage of total 
body weight (BW), the SMM index [SMMI] (Kg / m2), and creatinine height index (CHI) (%) in elderly individuals 
with walking difficulty were approximately 8-10 kg, 17-20% of BW, 3.9-4.6 kg / m2, and 44%, respectively. Serum 
25(OH)D concentrations were closely associated with SMM (kg, % of BW, kg / m2) and CHI (%) as well as the 
intestinal absorption rates of nitrogen (%) and phosphorus (%) in women, but not in men. The present results 
demonstrate that vitamin D is an important metabolic factor in skeletal muscle, and contributes to the optimal 
management of skeletal muscle and the prevention of sarcopenia. J. Med. Invest. 67 : 151-157, February, 2020
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                       intestinal absorption rate
INTRODUCTION
 
The aging of society in developed and developing countries has 
resulted in an increase in the number of elderly individuals who 
need human and social support. Older individuals with frailty 
are at a higher risk of falls and disability as well as nursing 
home placement and mortality (1). Skeletal muscle is the most 
abundant tissue in the human body, comprising 40-50% of the 
body mass, and plays vital roles in locomotion and glucose and 
energy metabolism (2). Skeletal muscle mass (SMM) has been 
identified as a reliable marker of frailty and a poor prognosis 
among the very elderly (3).
Creatine synthesized in the kidney and liver and from the 
diet is transported into the sarcoplasm against a concentration 
gradient. Up to 98% of total body creatine is found in skeletal 
muscle (4). The turnover of skeletal muscle creatine occurs as 
a result of the non-enzymatic, irreversible conversion of a small 
proportion of creatine to creatinine, and creatinine is rapidly and 
fully excreted in the urine. The creatine turnover rate constant 
for humans is reportedly 1.7% / day (5, 6). Therefore, 24-h creat-
inine excretion is used as a measure of total body SMM because 
urinary creatinine appears to be proportional to SMM and a re-
liable measure of SMM in patients with advanced renal failure, 
in children and adolescents, in the elderly, and in patients with 
wasting conditions (7-12).
The loss of SMM is a common issue in the elderly worldwide, 
with a prevalence ranging between 7% and more than 50% 
(13). A clearer understanding of SMM in middle-aged and 
elderly individuals is important for maintaining functionality, 
providing adequate rehabilitation and proper nursing care, and 
preventing a bedridden state. Sarcopenia is characterized by the 
progressive and generalized loss of skeletal mass and strength 
with a risk of adverse outcomes, such as physical disability and 
a poor quality of life (14-17). However, a correlation has not yet 
been found between muscle mass and muscle function (18, 19). 
Nutrition in SMM also plays an important role (20). In the pres-
ent study, age-related changes in SMM, the threshold of muscle 
mass on walking difficulty, the nutrient absorption rate, and 
serum electrolyte, mineral, and vitamin levels were examined in 
Japanese populations of various ages.
MATERIALS AND METHODS
Subjects
This was a cross-sectional study that investigated age-related 
changes in SMM and nutritional factors. The numbers of male 
and female subjects in the age groups of 21-30 years, 31-50 years, 
51-75 years and 76 years and older were 13 and 10, 13 and 11, 8 
and 15, and 2 and 16, respectively (Tables 1 and 2). Among them, 
the numbers of male and female subjects with walking difficulty 
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in nursing homes were 1 and 1 in the age group of 51-75 years 
and 2 and 16 in the age group of 76 years and older, respectively. 
These subjects were being cared for mainly by registered care 
workers and dietitians. Another 68 subjects aged between 21-75 
years old were healthy registered care workers and physical and 
occupational therapists in nursing homes, and teaching and 
administration staff in Kenshokai Gakuen College of Health 
and Welfare. None of the healthy subjects were engaged in high 
levels of exercise training or were taking any medications just 
before or during the study. Routine blood studies, including 
electrolytes, liver tests, and hematological indexes confirmed the 
health status of each subject before entry into the protocol.
Height and weight measurements were performed with the 
participants wearing light clothing and no shoes. BMI was 
calculated as weight (kg) divided by the square of height (m). 
In clinical laboratory tests, blood samples were collected from 
subjects who had undertaken a more than 8-hour overnight 
fast, immediately refrigerated, transported in cold storage to the 
SRL Laboratory in Tokyo, and analyzed within 24 hours. Serum 
25-hydroxyvitamin D [25(OH)D] levels, as an indicator of the vi-
tamin D status, were measured by an electrochemiluminescent 
immunoassay (ECLIA).
Measurement of SMM
Each subject provided two 24-h urine samples at inclusion on 
2 consecutive days. Creatinine excretion was calculated as the 
mean of the two 24-h urine collections. SMM was calculated 
from the 24-h urinary creatinine amount based on this equation 
(SMM (kg) = 21.8×Cr (g / day)) (10). The SMM index (SMMI) 
was calculated as body weight (BW) (kg) divided by the square 
of height (m). SMM (% of body weight (kg)) was calculated as 
weight (%) divided by BW (kg). The creatinine height index 
(CHI) was calculated from the following formula : 
CHI = 24-h urine creatinine excretion (mg) / expected 24-h 
urine creatinine excretion (23 mg / kg in males and 18 mg / kg in 
females) × 100. 
Estimated nitrogen balance was calculated as the difference 
between total nitrogen intake and total nitrogen output in 
urine. Nitrogen intake was calculated from nitrogen provided 
in food for each subject. The following formula was used to 
calculate the nitrogen balance : Nitrogen balance = 24-h pro-
tein uptake / 6.25 - (24-h nitrogen excretion / 0.8). The putative 
intestinal absorption rate of nitrogen, sodium, calcium, and 
phosphorus balance were assessed as the urinary excretion rate 
(%) defined as the amount of urinary excretion divided by the 
amount of oral food intake.
Statistical analysis
Data were expressed as the mean ± SD of male and female sub-
jects in different age groups. The Kruskal-Wallis test (non-para-















Height (cm) 170.8 ± 5.7 171.7 ± 3.3 163.5 ± 7.9 149.5 ± 0.7 p < 0.01
Body weight (kg) 69.9 ± 13.6 68.4 ± 8.7 64.9 ± 8.0 43.2 ± 7.1 ns
Body mass index (kg / m2) 24.4 ± 5.9 23.2 ± 3.1 24.2 ± 1.5 19.4 ± 3.0 ns
Skeletal muscle mass (kg) 34.5 ± 3.9 32.3 ± 8.2 29.1 ± 9.3 7.8 ± 3.1 p < 0.05
Skeletal muscle mass (% of body weight) 50.2 ± 9.0 47.7 ± 12.7 44.8 ± 13.8 17.5 ± 4.2 ns
Skeletal muscle mass index (kg / m2) 11.9 ± 1.7 11.0 ± 2.8 10.8 ± 3.2 3.5 ± 1.3 ns
Creatinine height index (%) 99.9 ± 17.9 97.0 ± 25.1 89.3 ± 27.7 38.8 ± 2.5 ns
Predicted intestinal absorption rate
Nitrogen (%) 84.2 ± 17.6 78.1 ± 15.4 87.2 ± 10.3 35.6 ± 6.6 ns
Sodium (%) 118.5 ± 61.0 79.8 ± 29.3 105.9 ± 35.2 77.7 ± 15.5 ns
Calcium (%) 13.3 ± 5.0 10.9 ± 3.7 22.9 ± 10.2 6.6 ± 5.6 p < 0.05
Phosphorus (%) 69.0 ± 17.6 60.0 ± 14.8 64.8 ± 13.9 18.8 ± 20.3 ns
Serum electrolyte, mineral, and vitamin levels
Sodium (mEq / L) 141.2 ± 1.7 140.8 ± 1.6 140.3 ± 1.9 139.0 ± 0.0 ns
Potassium (mEq / L) 4.2 ± 0.2 4.3 ± 0.4 4.0 ± 0.2 4.1 ± 0.4 ns
Chloride (mEq / L) 103.6 ± 1.4 102.2 ± 2.7 102.8 ± 2.6 103.0 ± 1.4 ns
Calcium (mg / dL) 9.5 ± 0.4 9.5 ± 0.3 9.1 ± 0.4 8.5 ± 0.1 p < 0.05
Phosphorus (mg / dL) 3.7 ± 0.4 3.6 ± 0.3 3.2 ± 0.6 3.4 ± 0.0 ns
Zinc(µg / dL) 92.8 ± 15.2 89.2 ± 12.8 90.5 ± 15.4 62.5 ± 24.7 ns
Iron (µg / dL) 100.7 ± 41.4 81.8 ± 23.6 73.4 ± 24.8 57.0 ± 18.4 ns
Copper (µg / dL) 89.8 ± 11.8 98.9 ± 15.7 101.8 ± 19.3 97.0 ± 11.3 ns
Folic acid (ng / mL) 6.0 ± 1.5 5.6 ± 2.5 6.7 ± 2.5 5.4 ± 1.5 ns
β-carotene (µg / dL) 17.1 ± 8.9 34.6 ± 44.2 30.3 ± 15.5 25.9 ns
25(OH)D (ng / mL) 17.8 ± 3.2 18.1 ± 4.4 16.6 ± 7.1 15.7 ± 9.5 ns
ns : not significant
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metric method) was used to assess the significance of differences 
between age groups in male and female subjects. Pearson’s 
analysis was used to examine the significance of differences 
between serum 25(OH)D levels and various values for SMM and 
the intestinal nutrition absorption rate. A p value less than 0.05 
was considered to indicate significance.
Ethical considerations
The protocol of this project was approved by the Institutional 
Review Board of the Hinomine Medical Center (Komatsushima, 
Tokushima, Japan). The procedures were fully explained to sub-
jects and an informed consent form was signed.
RESULTS
1) Age-related changes in SMM
The general characteristics of the different age groups in male 
and female subjects were shown in Tables 1 and 2, respectively. 
Significant age-related decreases in height, SMM (kg), the calci-
um absorption rate (%), and serum calcium levels were observed 
in men. In contrast, more significant age-related decreases in 
BW, height, SMM (kg, % of BW, kg / m2), CHI (%), serum so-
dium, calcium, phosphorus, and zinc levels, and the intestinal 
absorption rates of nitrogen (%), sodium (%), calcium (%), and 
phosphorus (%) were observed in women. 
The values for SMM (kg, % of BW, kg / m2) and CHI (%) in the 
21-30 year group were 34.5 ± 3.9 kg, 50.2 ± 9.0% of BW, 11.9 ± 1.7 
kg / m2, and 99.9 ± 17.9% in males, and 25.3 ± 6.2 kg, 47.5 ± 9.0% 
of BW, 10.1 ± 2.7 kg / m2, and 121.2 ± 23.2% in females, respec-
tively. In comparisons with SMM (kg, % of BW, kg /  m2) and CHI 
(%) in the 21-30 year group, those in males were 93.6, 95, 92.4, 
and 97.1% in the 31-50 year group, 84.3, 89.2, 90.6, and 89.4% 
in the 51-75 year group, and 22.6, 34.8, 29.4, and 33.8% in the 
76 years and older group, while those in females were 74.3, 73.3, 
75.2, and 74.0% in the 31-50 year group, 77.1, 65.9, 76.2, and 
65.8% in the 51-75 year group, and 31.2, 36.2, 37.6, and 36.1% in 
the 76 years and older group, respectively.
Thus, a more rapid decrease in SMM after the age of 31 
years was observed in women, whereas a marked reduction in 
SMM was noted after the age of 76 years in men. Furthermore, 
age-related reductions in serum 25(OH)D concentrations were 
observed in women, but not in men.
2) Cut-off values for SMM with walking difficulty
Cut-off values for SMM (kg), % of BW, kg / m2, and CHI (%) in 
male and female subjects with walking difficulty were 10.8 ± 5.8 
and 8.1 ± 3.3 kg, 20.8 ± 6.5 and 17.5 ± 6.3% of BW, 4.6 ± 2.2 and 
3.9 ± 1.7 kg / m2, and 44.3 ± 9.8 and 44.6 ± 16.1%, respectively. 
SMM (kg), % of BW, kg / m2, and CHI (%) were approximately 















Height (cm) 158.7 ± 6.1 157.6 ± 4.1 157.8 ± 7.6 144.2 ± 6.2 p < 0.001
Body weight (kg) 52.8 ± 4.1 55.8 ± 11.9 61.5 ± 13.4 44.9 ± 8.8 p < 0.01
Body mass index (kg / m2) 21.0 ± 1.7 22.5 ± 4.8 24.5 ± 4.2 21.6 ± 3.9 ns
Skeletal muscle mass (kg) 25.3 ± 6.2 18.8 ± 5.1 19.1 ± 5.3 7.9 ± 3.4 p < 0.001
Skeletal muscle mass (% of body weight) 47.5 ± 9.0 34.8 ± 12.3 31.3 ± 7.8 17.2 ± 6.4 p < 0.001
Skeletal muscle mass index (kg / m2) 10.1 ± 2.7 7.6 ± 2.2 7.7 ± 2.0 3.8 ± 1.7 p < 0.001
Creatinine height index (%) 121.2 ± 23.2 89.7 ± 30.4 79.8 ± 19.8 43.7 ± 16.2 p < 0.001
Predicted intestinal absorption rate
Nitrogen (%) 74.7 ± 16.4 53.0 ± 15.2 60.8 ± 18.7 40.0 ± 20.5 p < 0.001
Sodium (%) 117.3 ± 43.1 67.3 ± 15.1 85.3 ± 30.5 79.0 ± 22.0 p < 0.05
Calcium (%) 22.1 ± 14.9 9.1 ± 6.0 14.3 ± 8.2 10.3 ± 5.2 p < 0.05
Phosphorus (%) 55.6 ± 18.2 42.3 ± 11.0 48.3 ± 18.2 19.1 ± 13.9 p < 0.001
Serum electrolyte, mineral, and vitamin levels
Sodium (mEq / L) 141.1 ± 1.3 140.0 ± 1.1 141.1 ± 3.5 138.6 ± 4.1 p < 0.05
Potassium (mEq / L) 4.3 ± 0.3 4.2 ± 0.3 4.3 ± 0.5 4.4 ± 0.8 ns
Chloride (mEq / L) 104.9 ± 1.4 103.5 ± 1.4 102.6 ± 3.8 102.8 ± 5.1 ns
Calcium (mg / dL) 9.5 ± 0.3 9.2 ± 0.3 9.3 ± 0.4 8.6 ± 0.4 p < 0.001
Phosphorus (mg / dL) 3.9 ± 0.6 3.3 ± 0.6 3.5 ± 0.3 3.5 ± 0.3 p < 0.05
Zinc (µg / dL) 98.3 ± 14.0 90.7 ± 15.4 90.6 ± 13.0 77.9 ± 15.1 p < 0.05
Iron (µg / dL) 92.5 ± 50.4 91.8 ± 48.5 94.0 ± 25.6 66.2 ± 27.7 ns
Copper (µg / dL) 88.8 ± 16.6 100.3 ± 12.8 109.4 ± 18.3 114.7 ± 23.8 ns
Folic acid (ng / mL) 7.3 ± 1.5 7.3 ± 2.3 7.9 ± 4.8 10.4 ± 14.3 ns
β-carotene (µg / dL) 27.2 ± 12.9 41.3 ± 33.4 34.1 ± 16.7 33.1 ± 17.7 ns
25(OH)D (ng / mL) 17.0 ± 4.9 15.3 ± 4.3 12.9 ± 3.5 8.7 ± 2.3 p < 0.001
ns : not significant
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32, 39, 39, and 40% of those for young males and females in the 
21-30 year groups, respectively. All 20 subjects with walking 
difficulty were living in nursing homes and the rate was 60% (3 
in 5) in men and 94.4% (17 in 18) in women. 
3) Relationships between the vitamin D status, SMM, and intestinal 
nutrient absorption rates
The factors associated with differences in the 25(OH)D status 
with gender are shown in Table 3. Serum 25(OH)D concentra-
tions were closely associated with SMM (kg, % of BW, kg / m2), 
CHI (%), and the intestinal absorption rates of nitrogen (%) 
and phosphorus (%) in women, but not in men. A significant 
difference was observed in SMM based on the 25(OH)D status 
in women regardless of age, suggesting a lower mean value for 
SMM in those with hypovitaminosis. However, no significant 
differences were noted among men in the different age groups.
 
DISCUSSION
The recommended cut-off values for SMM diagnosed as sar-
copenia were obtained using a bioelectric impedance analysis 
(BIA) and dual-energy X-ray absorptiometry lean mass (DXA) 
in Asian and European populations (13, 21). BIA measures 
body conductivity or resistance to a small electrical current 
through the body or across a limb. Resistance is strongly related 
to total body water and is used to assess lean body mass. Thus, 
BIA does not directly measure skeletal muscle mass (22). DXA 
estimates body composition using a three compartment model. 
Fat and bone mineral contents are directly measured through 
the differential absorption of two photon energies, and then by 
subtraction, lean mass is obtained (23). Soft-tissue lean mass 
includes muscle mass, water, organ weight, and all other non-
bone and non-fat soft tissue. Therefore, DXA does not measure 
muscle mass specifically and does not provide an accurate mea-
surement of SMM in practice. In addition, computed tomography 
(CT) and magnetic resonance imaging (MRI) measurements of 
the cross-sectional area or whole body skeletal muscle mass are 
precise and applicable in small studies ; however, due to very 
high costs and radiation exposure (for CT), they are impractical 
for field studies.
The use of creatinine excretion provides a direct assessment of 
the whole body creatine pool size and, as a result, of muscle mass. 
This method has been used as an estimate of muscle mass (7-13, 
24, 25). CHI is another valid and very simple tool for assessing 
the protein status in patients with various diseases, including 
malnutrition. In the present study, CHI in the 21-30 year male 
and female groups was approximately 100-120%. Furthermore, 
the intestinal sodium absorption rate was constantly 80-110% 
in both males and females of different ages ; therefore, the mea-
surement of SMM using the amount of creatinine in 24-h urine 
collection may reflect total body creatinine and, consequently, 
total SMM. 
The present study also showed that reduced SMM was posi-
tively associated with a vitamin D deficiency in women. Previous 
findings indicated that the vitamin D receptor (VDR) for 1,25-di-
hydroxyvitamin D (1,25(OH)2D) was expressed in skeletal mus-
cle and was a crucial mediator of 1,25(OH)2D, thereby affecting 
muscle contractility (26). Age-related reductions in the expres-
sion of VDR in both muscle and bone are one feature suggesting 
that a decline in the vitamin D status plays an integral role in 
the functional link between sarcopenia and osteoporosis (27). 
25(OH)D levels are generally accepted to decrease longitudinally 
with age (28). This is attributed to both a decrease in the ability 
of cholecalciferol in the skin to make 25(OH)D and a decline in 
vitamin D absorption, as well as reduced sun exposure and the 
use of sunblock (29). 
There is a general consensus that serum 25(OH)D concentra-
tions of < 20 ng / mL, 20 to < 30 ng / mL, and ≥ 30 ng / mL indi-
cate a vitamin D deficiency, vitamin D insufficiency, and vitamin 
D sufficiency, respectively (30). Serum 25(OH)D concentrations 
in Japanese individuals aged 83.8 ± 7.6 and 85.4 ± 8.5 years 
were previously reported to be 9.7 ± 1.8 and 9.7 ± 3.7 ng / mL, 
respectively (31). In another study that examined institutional-
ized elderly patients from Buenos Aires, 41% of residents had a 
serum 25(OH)D level of less than 25 nmol / L (10 ng / mL) (32). 
In a study of 1585 osteoporotic Japanese women aged 70-95 
years, a multivariate liner regression analysis indicated that a 
low serum 25(OH)D level ( < 20 ng / mL) was an independent 
determinant of the total QOL score quartile (33). Their mean 
serum 25(OH)D level was 23.7 ng / mL. The numbers of subject 
with serum 25(OH)D levels of < 20 ng / mL, 20 to 30 ng / mL, 
and ≥ 30 ng / mL were 376 (23.7%), 982 (63.0%), and 227 (14.3%), 
respectively. Lower serum 25(OH)D levels were associated with 
a lower QOL score, and this relationship was clearly observed in 
patients with levels < 20 ng / mL.
Previous studies reported an inconsistent relationship be-
tween vitamin D and muscle mass in different sexes and age 
groups (34-40). Serum 25(OH)D levels in 40 healthy Japanese 
volunteers aged 42.0 ± 10.6 years old were 15.2 ± 5.4 ng / mL. 
This level was identified as a significant positive predictor for 
both the appendicular skeletal muscle index (kg / m2) and lower 
limb muscle strength, and female subjects had significantly 
lower serum 25(OH)D levels than males (41). The prevalence 
of a vitamin D sufficiency (plasma 25(OH)D concentration ≥ 30 
ng / mL) was extremely low (9.1%) in 9084 Japanese adults, and 
male gender was identified as a significant positive predictor 
(42). Thus, female gender is a significant risk factor for both a 
vitamin D deficiency and insufficiency. The higher frequency of 
sunscreen use in females may decrease serum 25(OH)D concen-
trations (43) because lower sun exposure has been identified as 
a significant contributor to a vitamin D deficiency. 1α,25(OH)2D 
receptor-mediated signaling is age-dependently impaired in 
intestinal cells (44). The relationship between duodenal TRPV6 
expression and 1,25(OH)2D was previously reported to differ in 
men and women (45). A linear regression showed a strong rela-
tionship with 1,25(OH)2D, which was unaffected by age in men. 
In contrast, there was no significant overall relationship with 
1,25(OH)2D, whereas a significant decrease was observed with 
age in women. The effects of age with lower median VDR levels 
were more significant in women than in men. These findings 
may explain the age-related reduction in serum 25(OH)D levels, 
intestinal nutrient absorption, including calcium, and SMM 
Table 3.　 Index associated with serum 25-hydroxyvitamin D levels 
by Pearson’s analysis
Male Female
Skeletal muscle mass (kg) 0.23 ns 0.62 p < 0.001
Skeletal muscle mass index (kg / m2) 0.15 ns 0.57 p < 0.001
Skeletal muscle mass
 (% of body weight) 0.16 ns 0.61 p < 0.001
Creatinine height index (%) 0.14 ns 0.61 p < 0.001
Predicted intestinal absorption rate
Nitrogen (%) 0.09 ns 0.41 p < 0.01
Sodium (%) -0.19 ns 0.02 ns
Calcium (%) -0.09 ns -0.05 ns
Phosphorus (%) 0.11 ns 0.53 p < 0.001
ns : not significant
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predominantly observed in women.
The present study indicated that 87% (20 out of 23 people) 
of participants living in nursing homes had walking difficulty 
because their serum 25(OH)D levels were extremely low. The 
results obtained support the hypothesis that muscle mass is 
strongly associated with the vitamin D nutritional status, par-
ticularly in women. These 20 residents with less SMM than ap-
proximately 8-10 kg, 17-20% of BW, 3.9-4.6 kg / m2, and less than 
44% of CHI were at a high risk of falling and required careful 
support for moving, bathing, toilet functions, and eating in daily 
living. Furthermore, the majority of women living in nursing 
homes showed decreased intestinal nitrogen (amino acids and 
peptides), calcium, and phosphorus absorption. In animals and 
humans, a decline occurs in intestinal calcium absorption with 
age, resulting in secondary hyperparathyroidism and bone loss 
(46-48). This decrease in calcium absorption was shown to cor-
relate with the decreased expression of intestinal TRPV6 and 
calbindin-D9k (49, 50). Undernutrition and the consumption of a 
less varied diet with aging are associated with a smaller muscle 
mass (51). Among diet-related factors, a low vitamin D level has 
been shown to influence declined muscle function and increase 
the risk of falling in the elderly (52, 53).
The present study had several limitations. The number of 
subjects recruited, particularly in the 76 years and older male 
group, was small. This may reflect the different p values between 
male and female subjects. Furthermore, the lower serum 25(OH)
D concentrations in elderly subjects with a sufficient food intake 
may be explained by lower sun exposure in nursing homes. In ad-
dition, intestinal nutrient absorption rates obtained from these 
urinary excretion rates may need to be calculated from their 
amounts in stool samples. However, the present results suggest 
that vitamin D is a key metabolic regulator in muscle cells that 
will contribute to the prevention and optimal management of 
sarcopenia.
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